Cs Diagnostics CORP 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
OTC.Pink
CS Diagnostics Corp. reported a significant increase in revenue for fiscal year 2025, primarily due to an Affiliate Revenue Agreement, while facing ongoing liquidity constraints and a material weakness in internal controls.